Glorifying in terms of volume, this industry ranks third across the globe. The turnover of this sector in India from a period from 2008 up to September 2009 was US$ 21.04 billion. The sales of a variety of medicinal drugs of the country were expected to be US$ 19.22 billion by the end of 2012. This sector casts to kinds of roles so as to ensure the safe side of drugs:
- To gather & access inevitable & vital information regarding the pills & their correlated side-effects necessary during medical trials.
- To examine the results of the medicines & addressing it to FDA. This report must contain all positive possibilities negative feedback which are experienced by the patients, once they reach the market.
The Government of India has provided immense support for the growth of these industries. Rablon Healthcare Pvt Ltd is an established pharmaceutical company in India which manufactures efficient quality medicinal products (both generic & branded) to convey appropriate healthcare. This organization makes the applications of latest technologies & modern science to manufacture drugs to treat dreadful illnesses like cardiovascular, gastrointestinal diseases, cancer, other infections.